Jeff Davies
Net worth: 468 237 $ as of 30/05/2026
Net worth: 468 237 $ as of 30/05/2026
Jeff Davies is currently an Independent Non-Executive Director at Starpharma Holdings Ltd. and a Partner & Founding Director at Centre For Biopharmaceutical Excellence.
Previously, he held positions as Senior Vice President-Sales & Marketing at Thomson Industries, Inc., Executive Vice President & General Manager at CSL Ltd., and Global Head-Plasma Product Research & Development at CSL Behring AG.
Dr. Davies obtained a doctorate degree from Monash University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/06/2025 | 929,687 ( 0.22% ) | 468 237 $ | 30/05/2026 |
| Companies | Position | Start |
|---|---|---|
| STARPHARMA HOLDINGS LIMITED | Director/Board Member | 31/03/2022 |
| Companies | Position | End |
|---|---|---|
| CSL LIMITED | Corporate Officer/Principal | - |
CSL Behring AG
CSL Behring AG BiotechnologyHealth Technology Develops biological products | Corporate Officer/Principal | - |
Thomson Industries, Inc.
Thomson Industries, Inc. Metal FabricationProducer Manufacturing Manufactures linear motion control products | Sales & Marketing | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
CSL Ltd.
CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Starpharma Holdings Ltd.
Starpharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of dendrimer products for pharmaceutical, life science & other applications | Health Technology |
Thomson Industries, Inc.
Thomson Industries, Inc. Metal FabricationProducer Manufacturing Manufactures linear motion control products | Producer Manufacturing |
Monash University
Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring AG
CSL Behring AG BiotechnologyHealth Technology Develops biological products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions